277 related articles for article (PubMed ID: 17047070)
21. Overexpressed androgen receptor linked to p21WAF1 silencing may be responsible for androgen independence and resistance to apoptosis of a prostate cancer cell line.
Wang LG; Ossowski L; Ferrari AC
Cancer Res; 2001 Oct; 61(20):7544-51. PubMed ID: 11606392
[TBL] [Abstract][Full Text] [Related]
22. Role of coordinated molecular alterations in the development of androgen-independent prostate cancer: an in vitro model that corroborates clinical observations.
Shi Y; Chatterjee SJ; Brands FH; Shi SR; Pootrakul L; Taylor CR; Datar R; Cote RJ
BJU Int; 2006 Jan; 97(1):170-8. PubMed ID: 16336351
[TBL] [Abstract][Full Text] [Related]
23. Requirement for NF-(kappa)B in interleukin-4-induced androgen receptor activation in prostate cancer cells.
Lee SO; Lou W; Nadiminty N; Lin X; Gao AC
Prostate; 2005 Jul; 64(2):160-7. PubMed ID: 15678501
[TBL] [Abstract][Full Text] [Related]
24. 3,3'-Diindolylmethane downregulates pro-survival pathway in hormone independent prostate cancer.
Garikapaty VP; Ashok BT; Tadi K; Mittelman A; Tiwari RK
Biochem Biophys Res Commun; 2006 Feb; 340(2):718-25. PubMed ID: 16380095
[TBL] [Abstract][Full Text] [Related]
25. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
26. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Murthy S; Agoulnik IU; Weigel NL
Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
[TBL] [Abstract][Full Text] [Related]
27. Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer.
Jiang C; Lee HJ; Li GX; Guo J; Malewicz B; Zhao Y; Lee EO; Lee HJ; Lee JH; Kim MS; Kim SH; Lu J
Cancer Res; 2006 Jan; 66(1):453-63. PubMed ID: 16397261
[TBL] [Abstract][Full Text] [Related]
28. Lysophosphatidic acid promotes survival of androgen-insensitive prostate cancer PC3 cells via activation of NF-kappaB.
Raj GV; Sekula JA; Guo R; Madden JF; Daaka Y
Prostate; 2004 Oct; 61(2):105-13. PubMed ID: 15305333
[TBL] [Abstract][Full Text] [Related]
29. Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP.
Zhu W; Zhang JS; Young CY
Carcinogenesis; 2001 Sep; 22(9):1399-403. PubMed ID: 11532861
[TBL] [Abstract][Full Text] [Related]
30. Androgen receptor signaling: mechanism of interleukin-6 inhibition.
Jia L; Choong CS; Ricciardelli C; Kim J; Tilley WD; Coetzee GA
Cancer Res; 2004 Apr; 64(7):2619-26. PubMed ID: 15059919
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-4 enhances prostate-specific antigen expression by activation of the androgen receptor and Akt pathway.
Lee SO; Lou W; Hou M; Onate SA; Gao AC
Oncogene; 2003 Sep; 22(39):7981-8. PubMed ID: 12970746
[TBL] [Abstract][Full Text] [Related]
32. Proteasome inhibitor PS-341 down-regulates prostate-specific antigen (PSA) and induces growth arrest and apoptosis of androgen-dependent human prostate cancer LNCaP cells.
Ikezoe T; Yang Y; Saito T; Koeffler HP; Taguchi H
Cancer Sci; 2004 Mar; 95(3):271-5. PubMed ID: 15016328
[TBL] [Abstract][Full Text] [Related]
33. Androgen receptor involvement in the progression of prostate cancer.
Suzuki H; Ueda T; Ichikawa T; Ito H
Endocr Relat Cancer; 2003 Jun; 10(2):209-16. PubMed ID: 12790784
[TBL] [Abstract][Full Text] [Related]
34. Indole-3-carbinol and prostate cancer.
Sarkar FH; Li Y
J Nutr; 2004 Dec; 134(12 Suppl):3493S-3498S. PubMed ID: 15570059
[TBL] [Abstract][Full Text] [Related]
35. Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP prostate cancer cells.
Yang L; Xie S; Jamaluddin MS; Altuwaijri S; Ni J; Kim E; Chen YT; Hu YC; Wang L; Chuang KH; Wu CT; Chang C
J Biol Chem; 2005 Sep; 280(39):33558-65. PubMed ID: 16061480
[TBL] [Abstract][Full Text] [Related]
36. Chemical ablation of androgen receptor in prostate cancer cells by the histone deacetylase inhibitor LAQ824.
Chen L; Meng S; Wang H; Bali P; Bai W; Li B; Atadja P; Bhalla KN; Wu J
Mol Cancer Ther; 2005 Sep; 4(9):1311-9. PubMed ID: 16170022
[TBL] [Abstract][Full Text] [Related]
37. Effects of vitamin C on androgen receptor mediated actions in human prostate adenocarcinoma cell line LAPC-4.
Wang MH; Abreu-Delgado Y; Young CY
Urology; 2003 Jul; 62(1):167-71. PubMed ID: 12837460
[TBL] [Abstract][Full Text] [Related]
38. The neuroendocrine-derived peptide parathyroid hormone-related protein promotes prostate cancer cell growth by stabilizing the androgen receptor.
DaSilva J; Gioeli D; Weber MJ; Parsons SJ
Cancer Res; 2009 Sep; 69(18):7402-11. PubMed ID: 19706771
[TBL] [Abstract][Full Text] [Related]
39. The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer.
Chatterjee B
Mol Cell Biochem; 2003 Nov; 253(1-2):89-101. PubMed ID: 14619959
[TBL] [Abstract][Full Text] [Related]
40. Development of a prostate-specific promoter for gene therapy against androgen-independent prostate cancer.
Furuhata S; Ide H; Miura Y; Yoshida T; Aoki K
Mol Ther; 2003 Mar; 7(3):366-74. PubMed ID: 12668132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
